Perioperative cessation of sodium-glucose cotransporter-2 inhibitors: 72 hours or seven days?

Affiliations

Comment

Hle Tan et al. Anaesth Intensive Care. 2018 Jul.

. 2018 Jul;46(4):425.

No abstract available

Comment in

In reply.
Kerridge R, Whyte I, Prior F, Luu J, Story DA. Kerridge R, et al. Anaesth Intensive Care. 2018 Jul;46(4):427-428. Anaesth Intensive Care. 2018. PMID: 29966120 No abstract available.

The good, the bad, and the ugly: sodium-glucose cotransporter-2 inhibitors (gliflozins) and perioperative diabetes.
Kerridge R, Whyte I, Prior F, Luu J, Story DA. Kerridge R, et al. Anaesth Intensive Care. 2018 Mar;46(2):155-158. doi: 10.1177/0310057X1804600202. Anaesth Intensive Care. 2018. PMID: 29519216 No abstract available.
Postoperative euglycaemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors (gliflozins): a report of two cases and review of the literature.
Chacko B, Whitley M, Beckmann U, Murray K, Rowley M. Chacko B, et al. Anaesth Intensive Care. 2018 Mar;46(2):215-219. doi: 10.1177/0310057X1804600212. Anaesth Intensive Care. 2018. PMID: 29519226